BridgeBio Pharma, Inc. (BBIO) › Weighted Average Diluted SharesBridgeBio Pharma, Inc. (BBIO) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 118.00M2021-12-31: 144.36M2022-12-31: 147.47M2023-12-31: 162.79M2024-12-31: 186.08M2025-12-31: 191.53M191.53M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31191.53M+2.9%2026-02-24From 2025-01-012024-12-31186.08M+14.3%2026-02-24From 2024-01-012023-12-31162.79M+10.4%2026-02-24From 2023-01-012022-12-31147.47M+2.2%2025-02-20From 2022-01-012021-12-31144.36M+22.3%2024-02-22From 2021-01-012020-12-31118.00M—2023-02-23From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)